| 9.2 |
27.5 |
GO:0060466 |
activation of meiosis involved in egg activation(GO:0060466) |
| 5.6 |
33.8 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 4.8 |
14.4 |
GO:0030827 |
negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
| 4.5 |
13.5 |
GO:1900738 |
positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 4.2 |
8.3 |
GO:2000344 |
positive regulation of acrosome reaction(GO:2000344) |
| 3.8 |
7.5 |
GO:0097117 |
guanylate kinase-associated protein clustering(GO:0097117) |
| 3.6 |
3.6 |
GO:0042756 |
drinking behavior(GO:0042756) |
| 3.1 |
12.6 |
GO:0021564 |
glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
| 3.0 |
8.9 |
GO:1904978 |
regulation of endosome organization(GO:1904978) positive regulation of endosome organization(GO:1904980) |
| 2.9 |
14.6 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 2.9 |
8.8 |
GO:1904049 |
negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
| 2.9 |
43.2 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
| 2.8 |
2.8 |
GO:1904048 |
regulation of spontaneous neurotransmitter secretion(GO:1904048) |
| 2.8 |
8.4 |
GO:0050975 |
sensory perception of touch(GO:0050975) |
| 2.6 |
7.7 |
GO:0060596 |
mammary placode formation(GO:0060596) |
| 2.5 |
22.7 |
GO:1900034 |
regulation of cellular response to heat(GO:1900034) |
| 2.4 |
7.3 |
GO:0010360 |
negative regulation of anion channel activity(GO:0010360) |
| 2.4 |
2.4 |
GO:0003383 |
apical constriction(GO:0003383) |
| 2.4 |
4.8 |
GO:0061097 |
regulation of protein tyrosine kinase activity(GO:0061097) |
| 2.4 |
9.6 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
| 2.4 |
12.0 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 2.4 |
12.0 |
GO:1990034 |
calcium ion export from cell(GO:1990034) |
| 2.3 |
2.3 |
GO:0060399 |
positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 2.2 |
2.2 |
GO:2000830 |
vacuolar phosphate transport(GO:0007037) vitamin D3 metabolic process(GO:0070640) positive regulation of parathyroid hormone secretion(GO:2000830) |
| 2.2 |
8.9 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 2.2 |
8.6 |
GO:1905167 |
positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 2.2 |
38.7 |
GO:0021684 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 2.1 |
4.2 |
GO:0048687 |
positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) |
| 2.1 |
6.3 |
GO:0021577 |
hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
| 2.1 |
16.5 |
GO:0021894 |
cerebral cortex GABAergic interneuron development(GO:0021894) |
| 2.0 |
10.1 |
GO:1904908 |
negative regulation of maintenance of sister chromatid cohesion(GO:0034092) negative regulation of maintenance of mitotic sister chromatid cohesion(GO:0034183) maintenance of mitotic sister chromatid cohesion, telomeric(GO:0099403) mitotic sister chromatid cohesion, telomeric(GO:0099404) regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904907) negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904908) |
| 2.0 |
6.0 |
GO:0043988 |
histone H3-S28 phosphorylation(GO:0043988) |
| 2.0 |
6.0 |
GO:0048294 |
negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 2.0 |
2.0 |
GO:0055005 |
ventricular cardiac myofibril assembly(GO:0055005) |
| 2.0 |
2.0 |
GO:0099525 |
presynaptic dense core granule exocytosis(GO:0099525) |
| 2.0 |
19.7 |
GO:0010459 |
negative regulation of heart rate(GO:0010459) |
| 2.0 |
7.9 |
GO:2000017 |
positive regulation of determination of dorsal identity(GO:2000017) |
| 2.0 |
15.8 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 2.0 |
9.8 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 2.0 |
9.8 |
GO:0071692 |
protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
| 2.0 |
11.7 |
GO:0034447 |
very-low-density lipoprotein particle clearance(GO:0034447) |
| 1.9 |
5.8 |
GO:0032242 |
regulation of nucleoside transport(GO:0032242) |
| 1.9 |
9.6 |
GO:0015871 |
choline transport(GO:0015871) |
| 1.9 |
11.5 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 1.9 |
9.5 |
GO:0010991 |
negative regulation of SMAD protein complex assembly(GO:0010991) |
| 1.9 |
19.1 |
GO:0046959 |
habituation(GO:0046959) |
| 1.9 |
9.5 |
GO:0070305 |
response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
| 1.9 |
3.8 |
GO:0061744 |
motor behavior(GO:0061744) |
| 1.9 |
13.2 |
GO:2001023 |
regulation of response to drug(GO:2001023) |
| 1.8 |
5.5 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
| 1.8 |
3.6 |
GO:0097112 |
gamma-aminobutyric acid receptor clustering(GO:0097112) |
| 1.8 |
5.4 |
GO:0017055 |
negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 1.8 |
7.2 |
GO:0021586 |
pons maturation(GO:0021586) |
| 1.8 |
7.1 |
GO:0036015 |
response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 1.8 |
3.5 |
GO:0035934 |
corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
| 1.8 |
14.2 |
GO:2000301 |
negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 1.7 |
5.2 |
GO:1903244 |
positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 1.7 |
5.2 |
GO:0060854 |
patterning of lymph vessels(GO:0060854) |
| 1.7 |
8.6 |
GO:0032485 |
regulation of Ral protein signal transduction(GO:0032485) |
| 1.7 |
5.1 |
GO:0050925 |
negative regulation of negative chemotaxis(GO:0050925) |
| 1.7 |
3.4 |
GO:0001978 |
regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) |
| 1.7 |
1.7 |
GO:0097116 |
gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
| 1.7 |
26.8 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 1.7 |
5.0 |
GO:0018103 |
protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 1.6 |
24.4 |
GO:0021902 |
commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 1.6 |
8.1 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 1.6 |
8.0 |
GO:1905075 |
occluding junction disassembly(GO:1905071) regulation of occluding junction disassembly(GO:1905073) positive regulation of occluding junction disassembly(GO:1905075) |
| 1.6 |
4.8 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
| 1.6 |
42.9 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 1.6 |
18.9 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 1.5 |
1.5 |
GO:0007172 |
signal complex assembly(GO:0007172) |
| 1.5 |
6.2 |
GO:0010891 |
negative regulation of sequestering of triglyceride(GO:0010891) |
| 1.5 |
23.1 |
GO:0032793 |
positive regulation of CREB transcription factor activity(GO:0032793) |
| 1.5 |
4.6 |
GO:0061669 |
spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
| 1.5 |
1.5 |
GO:0051365 |
cellular response to potassium ion starvation(GO:0051365) |
| 1.5 |
1.5 |
GO:0021966 |
corticospinal neuron axon guidance(GO:0021966) |
| 1.5 |
4.5 |
GO:1900149 |
positive regulation of Schwann cell migration(GO:1900149) |
| 1.5 |
11.9 |
GO:1900454 |
positive regulation of long term synaptic depression(GO:1900454) |
| 1.5 |
5.9 |
GO:2000546 |
positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
| 1.5 |
4.4 |
GO:0001543 |
ovarian follicle rupture(GO:0001543) |
| 1.5 |
1.5 |
GO:0045576 |
regulation of mast cell activation(GO:0033003) mast cell activation(GO:0045576) |
| 1.4 |
4.3 |
GO:0046881 |
positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
| 1.4 |
10.1 |
GO:0016185 |
synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 1.4 |
7.1 |
GO:0051012 |
microtubule sliding(GO:0051012) |
| 1.4 |
4.2 |
GO:0039533 |
regulation of MDA-5 signaling pathway(GO:0039533) |
| 1.4 |
5.4 |
GO:0032484 |
Ral protein signal transduction(GO:0032484) |
| 1.4 |
4.1 |
GO:0061526 |
acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
| 1.4 |
1.4 |
GO:1900449 |
regulation of glutamate receptor signaling pathway(GO:1900449) |
| 1.3 |
4.0 |
GO:1902528 |
regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 1.3 |
5.2 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 1.3 |
5.2 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 1.3 |
6.5 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
| 1.3 |
5.2 |
GO:0099590 |
neurotransmitter receptor internalization(GO:0099590) |
| 1.3 |
3.8 |
GO:0035621 |
ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
| 1.3 |
5.1 |
GO:0021882 |
regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
| 1.3 |
16.4 |
GO:0070842 |
aggresome assembly(GO:0070842) |
| 1.3 |
3.8 |
GO:0007525 |
somatic muscle development(GO:0007525) |
| 1.2 |
3.7 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 1.2 |
12.4 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 1.2 |
6.2 |
GO:0015803 |
branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 1.2 |
1.2 |
GO:0021764 |
amygdala development(GO:0021764) |
| 1.2 |
2.4 |
GO:0043031 |
negative regulation of macrophage activation(GO:0043031) |
| 1.2 |
8.3 |
GO:0035093 |
spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 1.2 |
3.5 |
GO:0035864 |
response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
| 1.2 |
3.5 |
GO:0015866 |
ADP transport(GO:0015866) |
| 1.2 |
9.3 |
GO:0021785 |
branchiomotor neuron axon guidance(GO:0021785) |
| 1.2 |
3.5 |
GO:0016256 |
N-glycan processing to lysosome(GO:0016256) |
| 1.2 |
9.3 |
GO:0032926 |
negative regulation of activin receptor signaling pathway(GO:0032926) |
| 1.2 |
3.5 |
GO:1905051 |
regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 1.1 |
3.4 |
GO:0098928 |
presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
| 1.1 |
1.1 |
GO:2000137 |
negative regulation of cell proliferation involved in heart morphogenesis(GO:2000137) |
| 1.1 |
8.0 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 1.1 |
4.6 |
GO:0099527 |
postsynapse to nucleus signaling pathway(GO:0099527) |
| 1.1 |
11.3 |
GO:0016191 |
synaptic vesicle uncoating(GO:0016191) |
| 1.1 |
3.4 |
GO:0060120 |
auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 1.1 |
6.7 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 1.1 |
2.2 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 1.1 |
4.4 |
GO:0097298 |
regulation of nucleus size(GO:0097298) |
| 1.1 |
1.1 |
GO:0018307 |
enzyme active site formation(GO:0018307) |
| 1.1 |
5.4 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 1.1 |
1.1 |
GO:0060137 |
maternal process involved in parturition(GO:0060137) |
| 1.1 |
11.9 |
GO:0032482 |
Rab protein signal transduction(GO:0032482) |
| 1.1 |
2.1 |
GO:0030866 |
cortical cytoskeleton organization(GO:0030865) cortical actin cytoskeleton organization(GO:0030866) |
| 1.1 |
2.1 |
GO:0021529 |
spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 1.1 |
5.3 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 1.1 |
3.2 |
GO:2001106 |
regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 1.1 |
6.4 |
GO:0061734 |
parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
| 1.1 |
6.3 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 1.1 |
3.2 |
GO:0018008 |
N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
| 1.1 |
4.2 |
GO:0000415 |
negative regulation of histone H3-K36 methylation(GO:0000415) |
| 1.0 |
6.3 |
GO:0042699 |
follicle-stimulating hormone signaling pathway(GO:0042699) |
| 1.0 |
3.1 |
GO:0046878 |
positive regulation of saliva secretion(GO:0046878) |
| 1.0 |
3.1 |
GO:0014054 |
positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
| 1.0 |
4.1 |
GO:0044268 |
multicellular organismal protein metabolic process(GO:0044268) |
| 1.0 |
4.1 |
GO:0035435 |
phosphate ion transmembrane transport(GO:0035435) |
| 1.0 |
13.2 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 1.0 |
6.1 |
GO:0060134 |
prepulse inhibition(GO:0060134) |
| 1.0 |
3.0 |
GO:0071880 |
adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
| 1.0 |
8.0 |
GO:0035507 |
regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 1.0 |
4.0 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 1.0 |
2.0 |
GO:0007158 |
neuron cell-cell adhesion(GO:0007158) |
| 1.0 |
4.9 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 1.0 |
3.9 |
GO:2000211 |
regulation of glutamate metabolic process(GO:2000211) |
| 1.0 |
7.8 |
GO:0015812 |
gamma-aminobutyric acid transport(GO:0015812) |
| 1.0 |
3.9 |
GO:0010693 |
negative regulation of alkaline phosphatase activity(GO:0010693) |
| 1.0 |
1.9 |
GO:0032227 |
negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 1.0 |
4.8 |
GO:0070100 |
negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
| 1.0 |
1.0 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 1.0 |
3.8 |
GO:0007195 |
adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
| 0.9 |
4.7 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 0.9 |
12.3 |
GO:1903960 |
negative regulation of anion transmembrane transport(GO:1903960) |
| 0.9 |
1.9 |
GO:0035441 |
cell migration involved in vasculogenesis(GO:0035441) |
| 0.9 |
0.9 |
GO:1902474 |
positive regulation of protein localization to synapse(GO:1902474) |
| 0.9 |
1.9 |
GO:2000973 |
regulation of pro-B cell differentiation(GO:2000973) |
| 0.9 |
2.8 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 0.9 |
3.8 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
| 0.9 |
0.9 |
GO:0090218 |
positive regulation of lipid kinase activity(GO:0090218) |
| 0.9 |
9.3 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.9 |
3.7 |
GO:0060763 |
mammary duct terminal end bud growth(GO:0060763) |
| 0.9 |
7.5 |
GO:0007194 |
negative regulation of adenylate cyclase activity(GO:0007194) |
| 0.9 |
0.9 |
GO:0071105 |
response to interleukin-11(GO:0071105) |
| 0.9 |
0.9 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.9 |
5.5 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.9 |
4.6 |
GO:1903527 |
positive regulation of membrane tubulation(GO:1903527) |
| 0.9 |
4.6 |
GO:0033031 |
positive regulation of neutrophil apoptotic process(GO:0033031) |
| 0.9 |
10.1 |
GO:0021957 |
corticospinal tract morphogenesis(GO:0021957) |
| 0.9 |
2.7 |
GO:0097309 |
cap1 mRNA methylation(GO:0097309) |
| 0.9 |
3.6 |
GO:0001956 |
positive regulation of neurotransmitter secretion(GO:0001956) |
| 0.9 |
72.2 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.9 |
2.7 |
GO:1903538 |
meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
| 0.9 |
11.6 |
GO:0051968 |
positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
| 0.9 |
2.7 |
GO:0033634 |
positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.9 |
5.4 |
GO:1903818 |
positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 0.9 |
8.9 |
GO:0007190 |
activation of adenylate cyclase activity(GO:0007190) |
| 0.9 |
2.7 |
GO:0038095 |
Fc-epsilon receptor signaling pathway(GO:0038095) |
| 0.9 |
0.9 |
GO:2001180 |
negative regulation of interleukin-10 secretion(GO:2001180) |
| 0.9 |
2.6 |
GO:0044028 |
DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 0.9 |
0.9 |
GO:0034139 |
regulation of toll-like receptor 3 signaling pathway(GO:0034139) positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
| 0.9 |
1.7 |
GO:1901228 |
positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
| 0.9 |
2.6 |
GO:0050982 |
detection of mechanical stimulus(GO:0050982) |
| 0.9 |
2.6 |
GO:0007621 |
negative regulation of female receptivity(GO:0007621) |
| 0.9 |
6.9 |
GO:0000042 |
protein targeting to Golgi(GO:0000042) |
| 0.9 |
5.1 |
GO:0071955 |
recycling endosome to Golgi transport(GO:0071955) |
| 0.8 |
2.5 |
GO:0031554 |
regulation of DNA-templated transcription, termination(GO:0031554) |
| 0.8 |
25.3 |
GO:2000463 |
positive regulation of excitatory postsynaptic potential(GO:2000463) |
| 0.8 |
4.2 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.8 |
3.4 |
GO:0061002 |
negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 0.8 |
3.3 |
GO:0001542 |
ovulation from ovarian follicle(GO:0001542) |
| 0.8 |
2.5 |
GO:0071873 |
response to norepinephrine(GO:0071873) |
| 0.8 |
4.1 |
GO:0031022 |
nuclear migration along microfilament(GO:0031022) |
| 0.8 |
1.6 |
GO:0007183 |
SMAD protein complex assembly(GO:0007183) |
| 0.8 |
2.5 |
GO:1905150 |
regulation of voltage-gated sodium channel activity(GO:1905150) |
| 0.8 |
4.9 |
GO:0045956 |
positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.8 |
6.5 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.8 |
4.9 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.8 |
12.2 |
GO:0070571 |
negative regulation of neuron projection regeneration(GO:0070571) |
| 0.8 |
6.5 |
GO:0033601 |
positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.8 |
5.7 |
GO:0055003 |
cardiac myofibril assembly(GO:0055003) |
| 0.8 |
1.6 |
GO:0031394 |
positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
| 0.8 |
4.8 |
GO:0009449 |
gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 0.8 |
0.8 |
GO:0002035 |
brain renin-angiotensin system(GO:0002035) |
| 0.8 |
7.9 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 0.8 |
0.8 |
GO:0046619 |
optic placode formation involved in camera-type eye formation(GO:0046619) |
| 0.8 |
0.8 |
GO:0060075 |
regulation of resting membrane potential(GO:0060075) |
| 0.8 |
21.8 |
GO:0010738 |
regulation of protein kinase A signaling(GO:0010738) |
| 0.8 |
3.9 |
GO:0010025 |
wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.8 |
2.3 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.8 |
2.3 |
GO:0045113 |
regulation of integrin biosynthetic process(GO:0045113) |
| 0.8 |
2.3 |
GO:1900365 |
cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.8 |
2.3 |
GO:0097500 |
receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.8 |
2.3 |
GO:0007352 |
zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.8 |
5.4 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.8 |
1.5 |
GO:1903978 |
regulation of microglial cell activation(GO:1903978) |
| 0.8 |
0.8 |
GO:0002710 |
negative regulation of T cell mediated immunity(GO:0002710) |
| 0.8 |
6.8 |
GO:0014850 |
response to muscle activity(GO:0014850) |
| 0.7 |
3.0 |
GO:0061000 |
negative regulation of dendritic spine development(GO:0061000) |
| 0.7 |
8.2 |
GO:0031340 |
positive regulation of vesicle fusion(GO:0031340) |
| 0.7 |
3.0 |
GO:0021730 |
trigeminal sensory nucleus development(GO:0021730) principal sensory nucleus of trigeminal nerve development(GO:0021740) negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.7 |
2.2 |
GO:0046416 |
D-amino acid metabolic process(GO:0046416) |
| 0.7 |
3.7 |
GO:0006537 |
glutamate biosynthetic process(GO:0006537) |
| 0.7 |
16.2 |
GO:0046854 |
phosphatidylinositol phosphorylation(GO:0046854) |
| 0.7 |
2.2 |
GO:2000170 |
positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 0.7 |
3.6 |
GO:0051684 |
maintenance of Golgi location(GO:0051684) |
| 0.7 |
0.7 |
GO:0065001 |
specification of axis polarity(GO:0065001) |
| 0.7 |
10.1 |
GO:2000300 |
regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.7 |
2.1 |
GO:0003349 |
epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
| 0.7 |
2.1 |
GO:0042196 |
dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
| 0.7 |
2.1 |
GO:0060437 |
lung growth(GO:0060437) |
| 0.7 |
2.1 |
GO:0033602 |
negative regulation of dopamine secretion(GO:0033602) |
| 0.7 |
2.8 |
GO:2000291 |
regulation of myoblast proliferation(GO:2000291) |
| 0.7 |
2.1 |
GO:0033689 |
negative regulation of osteoblast proliferation(GO:0033689) |
| 0.7 |
9.2 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.7 |
3.5 |
GO:0044860 |
protein localization to plasma membrane raft(GO:0044860) |
| 0.7 |
2.1 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 0.7 |
1.4 |
GO:1904179 |
positive regulation of adipose tissue development(GO:1904179) |
| 0.7 |
0.7 |
GO:0090526 |
regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.7 |
2.1 |
GO:0032240 |
negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
| 0.7 |
1.4 |
GO:0071372 |
cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
| 0.7 |
2.7 |
GO:0003376 |
sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.7 |
1.4 |
GO:1903181 |
regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
| 0.7 |
2.0 |
GO:0033092 |
positive regulation of immature T cell proliferation in thymus(GO:0033092) |
| 0.7 |
1.4 |
GO:0089700 |
protein kinase D signaling(GO:0089700) |
| 0.7 |
2.7 |
GO:0097494 |
regulation of vesicle size(GO:0097494) |
| 0.7 |
0.7 |
GO:0061502 |
early endosome to recycling endosome transport(GO:0061502) |
| 0.7 |
4.0 |
GO:0098967 |
exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.7 |
2.0 |
GO:0097026 |
dendritic cell dendrite assembly(GO:0097026) |
| 0.7 |
15.8 |
GO:0051703 |
social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
| 0.7 |
11.2 |
GO:0015701 |
bicarbonate transport(GO:0015701) |
| 0.7 |
2.0 |
GO:0051542 |
elastin biosynthetic process(GO:0051542) |
| 0.7 |
2.6 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.6 |
3.9 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.6 |
1.9 |
GO:0035585 |
calcium-mediated signaling using extracellular calcium source(GO:0035585) |
| 0.6 |
1.9 |
GO:1904861 |
excitatory synapse assembly(GO:1904861) |
| 0.6 |
4.5 |
GO:0050882 |
voluntary musculoskeletal movement(GO:0050882) |
| 0.6 |
1.9 |
GO:0046340 |
diacylglycerol catabolic process(GO:0046340) retrograde trans-synaptic signaling(GO:0098917) |
| 0.6 |
1.3 |
GO:0042939 |
glutathione transport(GO:0034635) oligopeptide transmembrane transport(GO:0035672) tripeptide transport(GO:0042939) |
| 0.6 |
3.2 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.6 |
0.6 |
GO:1900452 |
regulation of long term synaptic depression(GO:1900452) |
| 0.6 |
0.6 |
GO:2000812 |
regulation of barbed-end actin filament capping(GO:2000812) |
| 0.6 |
1.9 |
GO:0032915 |
positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 0.6 |
2.5 |
GO:0021698 |
cerebellar cortex structural organization(GO:0021698) |
| 0.6 |
1.9 |
GO:0048007 |
antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.6 |
2.5 |
GO:1903943 |
regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
| 0.6 |
3.7 |
GO:0030242 |
pexophagy(GO:0030242) |
| 0.6 |
3.7 |
GO:0070314 |
G1 to G0 transition(GO:0070314) |
| 0.6 |
1.2 |
GO:0070162 |
adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) negative regulation of adiponectin secretion(GO:0070164) |
| 0.6 |
1.8 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.6 |
2.5 |
GO:0035521 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.6 |
7.3 |
GO:0043517 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.6 |
3.6 |
GO:0060124 |
positive regulation of growth hormone secretion(GO:0060124) |
| 0.6 |
9.7 |
GO:0060314 |
regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.6 |
8.5 |
GO:0061577 |
calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
| 0.6 |
1.8 |
GO:0003357 |
noradrenergic neuron differentiation(GO:0003357) |
| 0.6 |
0.6 |
GO:1903044 |
protein localization to membrane raft(GO:1903044) |
| 0.6 |
2.4 |
GO:0061010 |
gall bladder development(GO:0061010) |
| 0.6 |
2.4 |
GO:0090283 |
regulation of protein glycosylation in Golgi(GO:0090283) |
| 0.6 |
0.6 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.6 |
1.2 |
GO:0071336 |
regulation of hair follicle cell proliferation(GO:0071336) positive regulation of hair follicle cell proliferation(GO:0071338) |
| 0.6 |
2.4 |
GO:0055071 |
cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
| 0.6 |
4.8 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
| 0.6 |
2.4 |
GO:2000832 |
negative regulation of steroid hormone secretion(GO:2000832) |
| 0.6 |
3.5 |
GO:0030950 |
establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.6 |
1.8 |
GO:0031133 |
regulation of axon diameter(GO:0031133) |
| 0.6 |
1.7 |
GO:0061762 |
CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.6 |
2.3 |
GO:0098937 |
dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
| 0.6 |
2.9 |
GO:0045213 |
neurotransmitter receptor metabolic process(GO:0045213) |
| 0.6 |
0.6 |
GO:0043402 |
glucocorticoid mediated signaling pathway(GO:0043402) |
| 0.6 |
1.7 |
GO:0021891 |
olfactory bulb interneuron development(GO:0021891) |
| 0.6 |
2.3 |
GO:0046684 |
response to pyrethroid(GO:0046684) |
| 0.6 |
8.0 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.6 |
1.7 |
GO:0019074 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.6 |
0.6 |
GO:1902473 |
regulation of protein localization to synapse(GO:1902473) |
| 0.6 |
6.8 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.6 |
1.1 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.6 |
2.3 |
GO:0032804 |
negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) dibasic protein processing(GO:0090472) |
| 0.6 |
1.7 |
GO:2000616 |
negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 0.5 |
1.1 |
GO:1902412 |
regulation of mitotic cytokinesis(GO:1902412) |
| 0.5 |
1.1 |
GO:0060025 |
regulation of synaptic activity(GO:0060025) |
| 0.5 |
0.5 |
GO:0060003 |
copper ion export(GO:0060003) |
| 0.5 |
0.5 |
GO:1901668 |
regulation of superoxide dismutase activity(GO:1901668) |
| 0.5 |
1.1 |
GO:0045086 |
positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
| 0.5 |
1.1 |
GO:0097155 |
fasciculation of sensory neuron axon(GO:0097155) |
| 0.5 |
4.2 |
GO:1901897 |
regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.5 |
0.5 |
GO:0021830 |
substrate-independent telencephalic tangential migration(GO:0021826) interneuron migration from the subpallium to the cortex(GO:0021830) substrate-independent telencephalic tangential interneuron migration(GO:0021843) |
| 0.5 |
2.1 |
GO:0090370 |
negative regulation of cholesterol efflux(GO:0090370) |
| 0.5 |
3.1 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.5 |
1.0 |
GO:0006497 |
protein lipidation(GO:0006497) lipoprotein biosynthetic process(GO:0042158) |
| 0.5 |
1.0 |
GO:0014898 |
muscle hypertrophy in response to stress(GO:0003299) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.5 |
4.6 |
GO:0045721 |
negative regulation of gluconeogenesis(GO:0045721) |
| 0.5 |
1.5 |
GO:0036228 |
protein targeting to nuclear inner membrane(GO:0036228) |
| 0.5 |
1.5 |
GO:1901421 |
positive regulation of response to alcohol(GO:1901421) |
| 0.5 |
2.6 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 0.5 |
1.5 |
GO:1903207 |
neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
| 0.5 |
1.5 |
GO:0007262 |
STAT protein import into nucleus(GO:0007262) |
| 0.5 |
1.5 |
GO:0035973 |
aggrephagy(GO:0035973) |
| 0.5 |
0.5 |
GO:0035022 |
positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.5 |
3.5 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.5 |
2.0 |
GO:0021604 |
cranial nerve structural organization(GO:0021604) |
| 0.5 |
4.4 |
GO:2000310 |
regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.5 |
2.0 |
GO:1900533 |
medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.5 |
1.5 |
GO:1905169 |
protein localization to phagocytic vesicle(GO:1905161) regulation of protein localization to phagocytic vesicle(GO:1905169) positive regulation of protein localization to phagocytic vesicle(GO:1905171) |
| 0.5 |
1.9 |
GO:0048739 |
cardiac muscle fiber development(GO:0048739) |
| 0.5 |
3.4 |
GO:0050908 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.5 |
7.3 |
GO:0045974 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.5 |
5.8 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.5 |
2.9 |
GO:0033139 |
regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) |
| 0.5 |
0.5 |
GO:0071317 |
cellular response to isoquinoline alkaloid(GO:0071317) |
| 0.5 |
1.0 |
GO:1905077 |
negative regulation of interleukin-17 production(GO:0032700) negative regulation of interleukin-17 secretion(GO:1905077) |
| 0.5 |
8.2 |
GO:1990126 |
retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.5 |
0.5 |
GO:0071374 |
cellular response to parathyroid hormone stimulus(GO:0071374) |
| 0.5 |
0.5 |
GO:0071680 |
response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 0.5 |
1.4 |
GO:0010641 |
positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
| 0.5 |
2.4 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.5 |
10.9 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 0.5 |
1.0 |
GO:0044313 |
protein K6-linked deubiquitination(GO:0044313) |
| 0.5 |
1.9 |
GO:0003430 |
growth plate cartilage chondrocyte growth(GO:0003430) |
| 0.5 |
3.8 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.5 |
1.4 |
GO:1902605 |
heterotrimeric G-protein complex assembly(GO:1902605) |
| 0.5 |
2.8 |
GO:0031034 |
myosin filament assembly(GO:0031034) |
| 0.5 |
0.9 |
GO:0097343 |
ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
| 0.5 |
4.7 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 0.5 |
4.2 |
GO:1902018 |
negative regulation of cilium assembly(GO:1902018) |
| 0.5 |
18.1 |
GO:0061512 |
protein localization to cilium(GO:0061512) |
| 0.5 |
1.8 |
GO:0016340 |
calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.5 |
2.3 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 0.5 |
0.5 |
GO:0034764 |
positive regulation of transmembrane transport(GO:0034764) |
| 0.5 |
2.7 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.5 |
0.5 |
GO:1902022 |
L-lysine transport(GO:1902022) |
| 0.5 |
2.3 |
GO:0002931 |
response to ischemia(GO:0002931) |
| 0.5 |
0.9 |
GO:1900745 |
positive regulation of p38MAPK cascade(GO:1900745) |
| 0.5 |
3.2 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.4 |
8.1 |
GO:0046928 |
regulation of neurotransmitter secretion(GO:0046928) |
| 0.4 |
1.3 |
GO:0035523 |
protein K29-linked deubiquitination(GO:0035523) |
| 0.4 |
1.8 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
| 0.4 |
2.2 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
| 0.4 |
1.3 |
GO:0051964 |
negative regulation of synapse assembly(GO:0051964) |
| 0.4 |
0.9 |
GO:0070863 |
positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.4 |
5.2 |
GO:0048520 |
positive regulation of behavior(GO:0048520) |
| 0.4 |
1.3 |
GO:0043323 |
positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.4 |
0.4 |
GO:0060159 |
regulation of dopamine receptor signaling pathway(GO:0060159) |
| 0.4 |
0.9 |
GO:0071929 |
alpha-tubulin acetylation(GO:0071929) |
| 0.4 |
1.3 |
GO:0042092 |
type 2 immune response(GO:0042092) |
| 0.4 |
1.7 |
GO:0072197 |
ureter morphogenesis(GO:0072197) |
| 0.4 |
3.9 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.4 |
1.7 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.4 |
3.0 |
GO:0038180 |
nerve growth factor signaling pathway(GO:0038180) |
| 0.4 |
1.3 |
GO:0009182 |
purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) GDP metabolic process(GO:0046710) |
| 0.4 |
0.4 |
GO:0006498 |
N-terminal protein lipidation(GO:0006498) |
| 0.4 |
1.3 |
GO:1904778 |
regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.4 |
5.5 |
GO:2001256 |
regulation of store-operated calcium entry(GO:2001256) |
| 0.4 |
2.1 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
| 0.4 |
0.8 |
GO:1903779 |
regulation of cardiac conduction(GO:1903779) |
| 0.4 |
0.8 |
GO:1901491 |
negative regulation of lymphangiogenesis(GO:1901491) |
| 0.4 |
0.4 |
GO:2000821 |
regulation of grooming behavior(GO:2000821) |
| 0.4 |
2.9 |
GO:0007413 |
axonal fasciculation(GO:0007413) |
| 0.4 |
1.6 |
GO:0001844 |
protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
| 0.4 |
0.4 |
GO:0072008 |
glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
| 0.4 |
1.2 |
GO:0036216 |
response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.4 |
5.3 |
GO:0045723 |
positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.4 |
3.6 |
GO:1901621 |
negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.4 |
2.4 |
GO:1901911 |
diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.4 |
1.6 |
GO:0046834 |
lipid phosphorylation(GO:0046834) |
| 0.4 |
17.3 |
GO:0031338 |
regulation of vesicle fusion(GO:0031338) |
| 0.4 |
0.8 |
GO:0010751 |
negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 0.4 |
2.0 |
GO:0006041 |
glucosamine metabolic process(GO:0006041) |
| 0.4 |
2.0 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.4 |
0.8 |
GO:0098528 |
skeletal muscle fiber differentiation(GO:0098528) |
| 0.4 |
6.7 |
GO:0030574 |
collagen catabolic process(GO:0030574) |
| 0.4 |
4.4 |
GO:2000580 |
positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.4 |
1.2 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.4 |
1.6 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.4 |
3.6 |
GO:0070072 |
vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.4 |
0.4 |
GO:2000807 |
regulation of synaptic vesicle clustering(GO:2000807) |
| 0.4 |
0.4 |
GO:0090494 |
catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
| 0.4 |
0.8 |
GO:0010701 |
positive regulation of norepinephrine secretion(GO:0010701) |
| 0.4 |
3.1 |
GO:0001964 |
startle response(GO:0001964) |
| 0.4 |
2.3 |
GO:0033169 |
histone H3-K9 demethylation(GO:0033169) |
| 0.4 |
1.5 |
GO:0071625 |
vocalization behavior(GO:0071625) |
| 0.4 |
3.1 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.4 |
0.8 |
GO:0021773 |
striatal medium spiny neuron differentiation(GO:0021773) |
| 0.4 |
3.4 |
GO:0001574 |
ganglioside biosynthetic process(GO:0001574) |
| 0.4 |
16.8 |
GO:0046580 |
negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
| 0.4 |
0.8 |
GO:0002669 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.4 |
11.8 |
GO:0036465 |
synaptic vesicle recycling(GO:0036465) |
| 0.4 |
0.4 |
GO:0042663 |
regulation of endodermal cell fate specification(GO:0042663) |
| 0.4 |
1.1 |
GO:0097091 |
synaptic vesicle clustering(GO:0097091) |
| 0.4 |
1.9 |
GO:0043983 |
histone H4-K12 acetylation(GO:0043983) |
| 0.4 |
13.4 |
GO:0048278 |
vesicle docking(GO:0048278) |
| 0.4 |
3.7 |
GO:1903861 |
positive regulation of dendrite extension(GO:1903861) |
| 0.4 |
1.1 |
GO:1900369 |
negative regulation of RNA interference(GO:1900369) |
| 0.4 |
2.6 |
GO:0030007 |
cellular potassium ion homeostasis(GO:0030007) |
| 0.4 |
0.7 |
GO:0002726 |
positive regulation of T cell cytokine production(GO:0002726) |
| 0.4 |
0.7 |
GO:0001922 |
B-1 B cell homeostasis(GO:0001922) |
| 0.4 |
1.1 |
GO:0010724 |
regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.4 |
1.4 |
GO:1903031 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.4 |
3.6 |
GO:0032411 |
positive regulation of transporter activity(GO:0032411) |
| 0.4 |
0.4 |
GO:0060032 |
notochord regression(GO:0060032) |
| 0.4 |
0.7 |
GO:0071205 |
protein localization to juxtaparanode region of axon(GO:0071205) |
| 0.4 |
2.5 |
GO:1902741 |
type I interferon secretion(GO:0072641) interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
| 0.4 |
1.8 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
| 0.4 |
0.4 |
GO:0060702 |
negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) |
| 0.4 |
5.3 |
GO:0002021 |
response to dietary excess(GO:0002021) |
| 0.4 |
1.4 |
GO:1903860 |
negative regulation of dendrite extension(GO:1903860) |
| 0.4 |
1.1 |
GO:2000569 |
T-helper 2 cell activation(GO:0035712) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
| 0.4 |
0.7 |
GO:0036258 |
multivesicular body assembly(GO:0036258) |
| 0.4 |
1.1 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.4 |
0.7 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.3 |
0.7 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.3 |
1.4 |
GO:0072362 |
regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072362) regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter(GO:0072368) |
| 0.3 |
5.9 |
GO:0046839 |
phospholipid dephosphorylation(GO:0046839) |
| 0.3 |
4.8 |
GO:0090110 |
cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.3 |
0.3 |
GO:1900736 |
regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
| 0.3 |
0.3 |
GO:0032911 |
negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.3 |
7.5 |
GO:0032292 |
myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.3 |
0.3 |
GO:1902460 |
regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.3 |
0.3 |
GO:0001865 |
NK T cell differentiation(GO:0001865) regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
| 0.3 |
11.3 |
GO:0099643 |
neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
| 0.3 |
1.7 |
GO:0031642 |
negative regulation of myelination(GO:0031642) |
| 0.3 |
0.3 |
GO:1905165 |
regulation of lysosomal protein catabolic process(GO:1905165) |
| 0.3 |
2.0 |
GO:0090315 |
negative regulation of protein targeting to membrane(GO:0090315) |
| 0.3 |
2.3 |
GO:0036444 |
calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.3 |
2.3 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.3 |
2.3 |
GO:0030382 |
sperm mitochondrion organization(GO:0030382) |
| 0.3 |
0.3 |
GO:0031645 |
negative regulation of neurological system process(GO:0031645) |
| 0.3 |
7.5 |
GO:0008210 |
estrogen metabolic process(GO:0008210) |
| 0.3 |
1.0 |
GO:0072720 |
response to dithiothreitol(GO:0072720) |
| 0.3 |
0.6 |
GO:0006601 |
creatine biosynthetic process(GO:0006601) |
| 0.3 |
1.3 |
GO:1902177 |
positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
| 0.3 |
1.0 |
GO:0016344 |
meiotic chromosome movement towards spindle pole(GO:0016344) |
| 0.3 |
1.3 |
GO:0060715 |
syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
| 0.3 |
5.8 |
GO:0007274 |
neuromuscular synaptic transmission(GO:0007274) |
| 0.3 |
1.0 |
GO:0046541 |
saliva secretion(GO:0046541) |
| 0.3 |
1.0 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.3 |
3.2 |
GO:0043696 |
dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
| 0.3 |
0.6 |
GO:0007197 |
adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 0.3 |
0.9 |
GO:0032225 |
regulation of synaptic transmission, dopaminergic(GO:0032225) positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
| 0.3 |
0.9 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.3 |
1.3 |
GO:0045779 |
negative regulation of bone resorption(GO:0045779) |
| 0.3 |
2.2 |
GO:0061718 |
NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 0.3 |
1.6 |
GO:0034398 |
telomere tethering at nuclear periphery(GO:0034398) |
| 0.3 |
1.3 |
GO:0043651 |
linoleic acid metabolic process(GO:0043651) |
| 0.3 |
0.9 |
GO:0018214 |
peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.3 |
6.9 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.3 |
0.9 |
GO:0045741 |
positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.3 |
1.6 |
GO:0014889 |
muscle atrophy(GO:0014889) |
| 0.3 |
1.2 |
GO:0002036 |
regulation of L-glutamate transport(GO:0002036) |
| 0.3 |
5.9 |
GO:0045746 |
negative regulation of Notch signaling pathway(GO:0045746) |
| 0.3 |
4.0 |
GO:0002446 |
neutrophil mediated immunity(GO:0002446) |
| 0.3 |
8.0 |
GO:0008333 |
endosome to lysosome transport(GO:0008333) |
| 0.3 |
6.7 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.3 |
2.4 |
GO:0010793 |
regulation of mRNA export from nucleus(GO:0010793) |
| 0.3 |
2.1 |
GO:0071971 |
extracellular exosome assembly(GO:0071971) regulation of extracellular exosome assembly(GO:1903551) |
| 0.3 |
0.6 |
GO:0061724 |
lipophagy(GO:0061724) regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 0.3 |
0.3 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.3 |
1.2 |
GO:0010172 |
embryonic body morphogenesis(GO:0010172) |
| 0.3 |
0.6 |
GO:1904354 |
negative regulation of telomere capping(GO:1904354) |
| 0.3 |
0.3 |
GO:0070070 |
proton-transporting V-type ATPase complex assembly(GO:0070070) |
| 0.3 |
1.8 |
GO:0015911 |
positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) plasma membrane long-chain fatty acid transport(GO:0015911) fatty acid transmembrane transport(GO:1902001) |
| 0.3 |
0.3 |
GO:0090219 |
negative regulation of lipid kinase activity(GO:0090219) |
| 0.3 |
0.3 |
GO:0032570 |
response to progesterone(GO:0032570) |
| 0.3 |
4.7 |
GO:0095500 |
acetylcholine receptor signaling pathway(GO:0095500) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
| 0.3 |
0.9 |
GO:0070166 |
enamel mineralization(GO:0070166) |
| 0.3 |
3.2 |
GO:0033622 |
integrin activation(GO:0033622) |
| 0.3 |
0.9 |
GO:0010730 |
negative regulation of hydrogen peroxide metabolic process(GO:0010727) negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 0.3 |
0.9 |
GO:0009644 |
response to high light intensity(GO:0009644) |
| 0.3 |
0.9 |
GO:1905245 |
regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) regulation of aspartic-type peptidase activity(GO:1905245) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 0.3 |
1.2 |
GO:1904953 |
Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904953) |
| 0.3 |
0.9 |
GO:0090394 |
negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 0.3 |
1.7 |
GO:0070294 |
renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
| 0.3 |
4.8 |
GO:0035249 |
synaptic transmission, glutamatergic(GO:0035249) |
| 0.3 |
4.2 |
GO:0099612 |
protein localization to axon(GO:0099612) |
| 0.3 |
4.7 |
GO:0007212 |
dopamine receptor signaling pathway(GO:0007212) |
| 0.3 |
1.1 |
GO:2000323 |
negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
| 0.3 |
1.4 |
GO:0033227 |
dsRNA transport(GO:0033227) |
| 0.3 |
0.6 |
GO:0043379 |
memory T cell differentiation(GO:0043379) |
| 0.3 |
1.7 |
GO:0060907 |
positive regulation of macrophage cytokine production(GO:0060907) |
| 0.3 |
0.8 |
GO:0098703 |
calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.3 |
0.6 |
GO:0097113 |
AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
| 0.3 |
1.1 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.3 |
0.3 |
GO:0097106 |
postsynaptic density organization(GO:0097106) |
| 0.3 |
1.1 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.3 |
1.6 |
GO:0070262 |
peptidyl-serine dephosphorylation(GO:0070262) |
| 0.3 |
0.5 |
GO:0071313 |
cellular response to caffeine(GO:0071313) |
| 0.3 |
1.6 |
GO:0051386 |
regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 0.3 |
1.1 |
GO:0015825 |
L-serine transport(GO:0015825) |
| 0.3 |
8.4 |
GO:0006891 |
intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.3 |
1.4 |
GO:0009181 |
purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.3 |
1.1 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.3 |
0.5 |
GO:0071867 |
response to monoamine(GO:0071867) cellular response to monoamine stimulus(GO:0071868) response to catecholamine(GO:0071869) cellular response to catecholamine stimulus(GO:0071870) |
| 0.3 |
0.3 |
GO:0033239 |
negative regulation of cellular amine metabolic process(GO:0033239) |
| 0.3 |
1.9 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.3 |
2.1 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.3 |
0.5 |
GO:0090325 |
regulation of locomotion involved in locomotory behavior(GO:0090325) |
| 0.3 |
0.3 |
GO:0048633 |
positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 0.3 |
1.8 |
GO:0032098 |
regulation of appetite(GO:0032098) |
| 0.3 |
2.1 |
GO:1901339 |
regulation of store-operated calcium channel activity(GO:1901339) |
| 0.3 |
1.3 |
GO:0015817 |
histidine transport(GO:0015817) |
| 0.3 |
0.5 |
GO:0042420 |
dopamine catabolic process(GO:0042420) |
| 0.3 |
2.3 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.3 |
2.3 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.3 |
1.6 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.3 |
1.3 |
GO:1900246 |
positive regulation of RIG-I signaling pathway(GO:1900246) |
| 0.3 |
5.9 |
GO:2001222 |
regulation of neuron migration(GO:2001222) |
| 0.3 |
1.8 |
GO:0070536 |
protein K63-linked deubiquitination(GO:0070536) |
| 0.3 |
1.5 |
GO:0097369 |
sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.3 |
0.5 |
GO:0021933 |
radial glia guided migration of cerebellar granule cell(GO:0021933) |
| 0.3 |
1.3 |
GO:2000427 |
positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.3 |
0.3 |
GO:0042769 |
DNA damage response, detection of DNA damage(GO:0042769) |
| 0.3 |
0.5 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.3 |
3.5 |
GO:1904294 |
positive regulation of ERAD pathway(GO:1904294) |
| 0.3 |
2.8 |
GO:0032060 |
bleb assembly(GO:0032060) |
| 0.3 |
0.3 |
GO:0051771 |
negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
| 0.2 |
3.0 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.2 |
1.0 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.2 |
3.5 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.2 |
1.5 |
GO:1902988 |
neuronal signal transduction(GO:0023041) macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
| 0.2 |
2.0 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.2 |
3.7 |
GO:2000042 |
negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.2 |
4.4 |
GO:0006054 |
N-acetylneuraminate metabolic process(GO:0006054) |
| 0.2 |
1.5 |
GO:0014010 |
Schwann cell proliferation(GO:0014010) |
| 0.2 |
0.2 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.2 |
1.7 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 0.2 |
2.4 |
GO:0008090 |
retrograde axonal transport(GO:0008090) |
| 0.2 |
0.5 |
GO:2001274 |
negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
| 0.2 |
1.4 |
GO:0048934 |
peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.2 |
1.0 |
GO:0010820 |
positive regulation of T cell chemotaxis(GO:0010820) |
| 0.2 |
3.8 |
GO:0007270 |
neuron-neuron synaptic transmission(GO:0007270) |
| 0.2 |
0.5 |
GO:0045924 |
regulation of female receptivity(GO:0045924) positive regulation of female receptivity(GO:0045925) |
| 0.2 |
0.7 |
GO:2000620 |
positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 0.2 |
1.2 |
GO:1900273 |
positive regulation of long-term synaptic potentiation(GO:1900273) |
| 0.2 |
16.3 |
GO:0016579 |
protein deubiquitination(GO:0016579) |
| 0.2 |
1.9 |
GO:0006883 |
cellular sodium ion homeostasis(GO:0006883) |
| 0.2 |
0.7 |
GO:0045654 |
positive regulation of megakaryocyte differentiation(GO:0045654) |
| 0.2 |
1.9 |
GO:0048711 |
positive regulation of astrocyte differentiation(GO:0048711) |
| 0.2 |
1.2 |
GO:0033138 |
positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
| 0.2 |
1.6 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.2 |
0.2 |
GO:1902256 |
apoptotic process involved in outflow tract morphogenesis(GO:0003275) regulation of apoptotic process involved in outflow tract morphogenesis(GO:1902256) |
| 0.2 |
2.5 |
GO:0031936 |
negative regulation of chromatin silencing(GO:0031936) |
| 0.2 |
0.7 |
GO:0075044 |
autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.2 |
0.5 |
GO:0035630 |
bone mineralization involved in bone maturation(GO:0035630) |
| 0.2 |
0.2 |
GO:0072425 |
signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
| 0.2 |
0.5 |
GO:0071157 |
negative regulation of cell cycle arrest(GO:0071157) |
| 0.2 |
1.6 |
GO:0008228 |
opsonization(GO:0008228) |
| 0.2 |
1.8 |
GO:0030578 |
PML body organization(GO:0030578) |
| 0.2 |
0.5 |
GO:0031584 |
activation of phospholipase D activity(GO:0031584) |
| 0.2 |
0.2 |
GO:0046501 |
protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.2 |
0.5 |
GO:0061469 |
regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.2 |
0.9 |
GO:2000671 |
regulation of motor neuron apoptotic process(GO:2000671) |
| 0.2 |
0.5 |
GO:0036003 |
positive regulation of transcription from RNA polymerase II promoter in response to stress(GO:0036003) |
| 0.2 |
0.2 |
GO:0016557 |
peroxisome membrane biogenesis(GO:0016557) |
| 0.2 |
1.3 |
GO:0097119 |
postsynaptic density protein 95 clustering(GO:0097119) |
| 0.2 |
0.2 |
GO:0060789 |
hair follicle placode formation(GO:0060789) |
| 0.2 |
0.2 |
GO:0007176 |
regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
| 0.2 |
0.2 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
| 0.2 |
0.7 |
GO:0003009 |
skeletal muscle contraction(GO:0003009) |
| 0.2 |
4.4 |
GO:0050650 |
chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 0.2 |
0.2 |
GO:0071276 |
cellular response to cadmium ion(GO:0071276) |
| 0.2 |
0.7 |
GO:0006517 |
protein deglycosylation(GO:0006517) |
| 0.2 |
0.4 |
GO:0046173 |
polyol biosynthetic process(GO:0046173) |
| 0.2 |
0.2 |
GO:0061470 |
T follicular helper cell differentiation(GO:0061470) |
| 0.2 |
0.7 |
GO:0048239 |
negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
| 0.2 |
4.2 |
GO:0097150 |
neuronal stem cell population maintenance(GO:0097150) |
| 0.2 |
0.7 |
GO:0051281 |
positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) |
| 0.2 |
7.2 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.2 |
0.9 |
GO:1904424 |
regulation of GTP binding(GO:1904424) |
| 0.2 |
1.5 |
GO:0043653 |
mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.2 |
3.0 |
GO:1901184 |
regulation of ERBB signaling pathway(GO:1901184) |
| 0.2 |
0.9 |
GO:0016128 |
phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
| 0.2 |
0.4 |
GO:0044034 |
negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.2 |
1.9 |
GO:0048305 |
immunoglobulin secretion(GO:0048305) |
| 0.2 |
2.1 |
GO:0010839 |
negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.2 |
12.8 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) |
| 0.2 |
1.1 |
GO:0097646 |
dimeric G-protein coupled receptor signaling pathway(GO:0038042) calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 0.2 |
2.1 |
GO:0090331 |
negative regulation of platelet aggregation(GO:0090331) |
| 0.2 |
0.6 |
GO:0072530 |
purine-containing compound transmembrane transport(GO:0072530) |
| 0.2 |
0.8 |
GO:0033005 |
positive regulation of mast cell activation(GO:0033005) positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.2 |
0.4 |
GO:0050703 |
interleukin-1 alpha secretion(GO:0050703) |
| 0.2 |
1.7 |
GO:0048505 |
regulation of timing of cell differentiation(GO:0048505) |
| 0.2 |
0.6 |
GO:0042045 |
epithelial fluid transport(GO:0042045) |
| 0.2 |
5.0 |
GO:0006906 |
vesicle fusion(GO:0006906) |
| 0.2 |
0.2 |
GO:0010046 |
response to mycotoxin(GO:0010046) |
| 0.2 |
0.8 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.2 |
2.9 |
GO:0061462 |
protein localization to lysosome(GO:0061462) |
| 0.2 |
7.2 |
GO:0046329 |
negative regulation of JNK cascade(GO:0046329) |
| 0.2 |
0.4 |
GO:0035461 |
vitamin transmembrane transport(GO:0035461) |
| 0.2 |
1.0 |
GO:0032957 |
inositol trisphosphate metabolic process(GO:0032957) |
| 0.2 |
2.9 |
GO:0070544 |
histone H3-K36 demethylation(GO:0070544) |
| 0.2 |
1.0 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.2 |
3.0 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
| 0.2 |
1.8 |
GO:0045761 |
regulation of adenylate cyclase activity(GO:0045761) |
| 0.2 |
3.4 |
GO:0016601 |
Rac protein signal transduction(GO:0016601) |
| 0.2 |
1.2 |
GO:0002328 |
pro-B cell differentiation(GO:0002328) |
| 0.2 |
0.4 |
GO:0070417 |
cellular response to cold(GO:0070417) |
| 0.2 |
2.2 |
GO:0044144 |
regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
| 0.2 |
0.8 |
GO:0009212 |
dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
| 0.2 |
0.2 |
GO:0097211 |
response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.2 |
1.4 |
GO:1900372 |
negative regulation of nucleotide biosynthetic process(GO:0030809) negative regulation of purine nucleotide biosynthetic process(GO:1900372) |
| 0.2 |
0.8 |
GO:0032801 |
receptor catabolic process(GO:0032801) |
| 0.2 |
0.8 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.2 |
18.8 |
GO:0035023 |
regulation of Rho protein signal transduction(GO:0035023) |
| 0.2 |
0.8 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.2 |
0.6 |
GO:0046168 |
glycerol-3-phosphate catabolic process(GO:0046168) |
| 0.2 |
1.2 |
GO:0034067 |
protein localization to Golgi apparatus(GO:0034067) |
| 0.2 |
7.4 |
GO:0060998 |
regulation of dendritic spine development(GO:0060998) |
| 0.2 |
4.0 |
GO:0006836 |
neurotransmitter transport(GO:0006836) |
| 0.2 |
1.1 |
GO:0043117 |
positive regulation of vascular permeability(GO:0043117) |
| 0.2 |
0.8 |
GO:0019673 |
GDP-mannose metabolic process(GO:0019673) |
| 0.2 |
0.9 |
GO:0007041 |
lysosomal transport(GO:0007041) |
| 0.2 |
0.6 |
GO:0072014 |
proximal tubule development(GO:0072014) |
| 0.2 |
0.7 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.2 |
1.3 |
GO:0030969 |
mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) |
| 0.2 |
0.6 |
GO:0035902 |
response to immobilization stress(GO:0035902) |
| 0.2 |
0.6 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
| 0.2 |
1.3 |
GO:1902083 |
negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
| 0.2 |
0.4 |
GO:0048680 |
positive regulation of axon regeneration(GO:0048680) |
| 0.2 |
0.9 |
GO:1990564 |
protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.2 |
0.5 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.2 |
4.9 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.2 |
0.4 |
GO:0071963 |
establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.2 |
0.4 |
GO:0021852 |
pyramidal neuron migration(GO:0021852) |
| 0.2 |
0.7 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.2 |
2.3 |
GO:0031937 |
positive regulation of chromatin silencing(GO:0031937) |
| 0.2 |
0.5 |
GO:0036010 |
protein localization to endosome(GO:0036010) |
| 0.2 |
22.0 |
GO:0042787 |
protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.2 |
1.7 |
GO:0006491 |
N-glycan processing(GO:0006491) |
| 0.2 |
0.3 |
GO:0010986 |
positive regulation of lipoprotein particle clearance(GO:0010986) |
| 0.2 |
1.6 |
GO:0006044 |
N-acetylglucosamine metabolic process(GO:0006044) |
| 0.2 |
0.7 |
GO:1904177 |
regulation of adipose tissue development(GO:1904177) |
| 0.2 |
2.7 |
GO:0060078 |
regulation of postsynaptic membrane potential(GO:0060078) |
| 0.2 |
0.3 |
GO:0002606 |
dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
| 0.2 |
0.5 |
GO:0019482 |
beta-alanine metabolic process(GO:0019482) |
| 0.2 |
0.2 |
GO:0090148 |
membrane fission(GO:0090148) |
| 0.2 |
1.9 |
GO:0010603 |
regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.2 |
0.7 |
GO:0034720 |
histone H3-K4 demethylation(GO:0034720) |
| 0.2 |
0.5 |
GO:0042304 |
regulation of fatty acid biosynthetic process(GO:0042304) |
| 0.2 |
1.0 |
GO:0043551 |
regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
| 0.2 |
0.7 |
GO:1904181 |
positive regulation of membrane depolarization(GO:1904181) |
| 0.2 |
0.3 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.2 |
0.3 |
GO:0021546 |
rhombomere development(GO:0021546) |
| 0.2 |
1.0 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.2 |
1.3 |
GO:0015838 |
amino-acid betaine transport(GO:0015838) |
| 0.2 |
0.5 |
GO:0021914 |
negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
| 0.2 |
2.1 |
GO:0006895 |
Golgi to endosome transport(GO:0006895) |
| 0.2 |
1.3 |
GO:0071243 |
cellular response to arsenic-containing substance(GO:0071243) |
| 0.2 |
1.3 |
GO:1903874 |
ferrous iron transmembrane transport(GO:1903874) |
| 0.2 |
0.9 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.2 |
0.6 |
GO:0044565 |
dendritic cell proliferation(GO:0044565) |
| 0.2 |
1.4 |
GO:0044539 |
long-chain fatty acid import(GO:0044539) |
| 0.2 |
0.6 |
GO:2000651 |
positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.2 |
0.6 |
GO:0014047 |
glutamate secretion(GO:0014047) |
| 0.2 |
0.5 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.2 |
1.4 |
GO:0071044 |
histone mRNA catabolic process(GO:0071044) |
| 0.2 |
0.6 |
GO:0006689 |
ganglioside catabolic process(GO:0006689) |
| 0.1 |
0.1 |
GO:1902915 |
negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.1 |
1.2 |
GO:0045351 |
type I interferon biosynthetic process(GO:0045351) |
| 0.1 |
0.3 |
GO:0010763 |
positive regulation of fibroblast migration(GO:0010763) |
| 0.1 |
0.4 |
GO:0042780 |
tRNA 3'-end processing(GO:0042780) |
| 0.1 |
0.1 |
GO:0030813 |
positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
| 0.1 |
0.4 |
GO:0051095 |
regulation of helicase activity(GO:0051095) |
| 0.1 |
1.3 |
GO:0055090 |
acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
| 0.1 |
0.3 |
GO:0019343 |
cysteine biosynthetic process via cystathionine(GO:0019343) cysteine biosynthetic process(GO:0019344) |
| 0.1 |
0.4 |
GO:0090521 |
glomerular visceral epithelial cell migration(GO:0090521) |
| 0.1 |
0.1 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.1 |
0.3 |
GO:0098532 |
histone H3-K27 trimethylation(GO:0098532) |
| 0.1 |
1.9 |
GO:0021860 |
pyramidal neuron development(GO:0021860) |
| 0.1 |
0.3 |
GO:0090308 |
regulation of methylation-dependent chromatin silencing(GO:0090308) |
| 0.1 |
0.3 |
GO:1901550 |
regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
| 0.1 |
0.3 |
GO:0022617 |
extracellular matrix disassembly(GO:0022617) |
| 0.1 |
0.9 |
GO:0034770 |
histone H4-K20 methylation(GO:0034770) |
| 0.1 |
0.1 |
GO:0061050 |
regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
| 0.1 |
0.4 |
GO:0046952 |
ketone body catabolic process(GO:0046952) |
| 0.1 |
1.4 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.1 |
1.1 |
GO:0033572 |
transferrin transport(GO:0033572) |
| 0.1 |
0.6 |
GO:0032527 |
retrograde protein transport, ER to cytosol(GO:0030970) protein exit from endoplasmic reticulum(GO:0032527) |
| 0.1 |
0.6 |
GO:0070966 |
nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.1 |
1.0 |
GO:0032380 |
regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.1 |
1.4 |
GO:0060235 |
lens induction in camera-type eye(GO:0060235) |
| 0.1 |
0.8 |
GO:0048194 |
Golgi vesicle budding(GO:0048194) |
| 0.1 |
0.5 |
GO:1990573 |
potassium ion import across plasma membrane(GO:1990573) |
| 0.1 |
2.0 |
GO:0097352 |
autophagosome maturation(GO:0097352) |
| 0.1 |
0.5 |
GO:0072384 |
organelle transport along microtubule(GO:0072384) |
| 0.1 |
0.3 |
GO:0001553 |
luteinization(GO:0001553) |
| 0.1 |
0.1 |
GO:0070375 |
ERK5 cascade(GO:0070375) |
| 0.1 |
0.1 |
GO:1903774 |
positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.1 |
0.4 |
GO:0061428 |
negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.1 |
0.5 |
GO:0090298 |
negative regulation of mitochondrial DNA replication(GO:0090298) negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
| 0.1 |
0.9 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.1 |
2.0 |
GO:0071526 |
semaphorin-plexin signaling pathway(GO:0071526) |
| 0.1 |
4.1 |
GO:0046513 |
ceramide biosynthetic process(GO:0046513) |
| 0.1 |
0.5 |
GO:1903025 |
regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.1 |
0.4 |
GO:0048298 |
positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 0.1 |
1.0 |
GO:0035887 |
aortic smooth muscle cell differentiation(GO:0035887) |
| 0.1 |
0.4 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.1 |
0.1 |
GO:0034372 |
very-low-density lipoprotein particle remodeling(GO:0034372) |
| 0.1 |
0.4 |
GO:0006072 |
glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.1 |
0.4 |
GO:0030049 |
muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.1 |
1.0 |
GO:0033599 |
regulation of mammary gland epithelial cell proliferation(GO:0033599) |
| 0.1 |
0.5 |
GO:0032298 |
positive regulation of DNA-dependent DNA replication initiation(GO:0032298) |
| 0.1 |
0.5 |
GO:1901475 |
pyruvate transmembrane transport(GO:1901475) |
| 0.1 |
0.5 |
GO:0035608 |
protein deglutamylation(GO:0035608) |
| 0.1 |
1.4 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.1 |
0.2 |
GO:0051482 |
positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
| 0.1 |
1.3 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.1 |
1.8 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.1 |
0.2 |
GO:2001206 |
positive regulation of osteoclast development(GO:2001206) |
| 0.1 |
0.2 |
GO:0035434 |
copper ion transmembrane transport(GO:0035434) |
| 0.1 |
0.6 |
GO:0032507 |
maintenance of protein location in cell(GO:0032507) |
| 0.1 |
0.2 |
GO:0002842 |
positive regulation of T cell mediated immune response to tumor cell(GO:0002842) |
| 0.1 |
0.2 |
GO:1903054 |
negative regulation of extracellular matrix organization(GO:1903054) |
| 0.1 |
0.5 |
GO:0045607 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.1 |
0.2 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.1 |
1.0 |
GO:0098907 |
regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) T-tubule organization(GO:0033292) protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) regulation of SA node cell action potential(GO:0098907) |
| 0.1 |
0.5 |
GO:0097039 |
protein linear polyubiquitination(GO:0097039) |
| 0.1 |
0.8 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.1 |
0.2 |
GO:0070200 |
establishment of protein localization to telomere(GO:0070200) |
| 0.1 |
0.2 |
GO:0051295 |
establishment of meiotic spindle localization(GO:0051295) formin-nucleated actin cable assembly(GO:0070649) |
| 0.1 |
1.1 |
GO:0000712 |
resolution of meiotic recombination intermediates(GO:0000712) |
| 0.1 |
11.4 |
GO:0006813 |
potassium ion transport(GO:0006813) |
| 0.1 |
0.1 |
GO:2000834 |
androgen secretion(GO:0035935) testosterone secretion(GO:0035936) regulation of androgen secretion(GO:2000834) regulation of testosterone secretion(GO:2000843) |
| 0.1 |
0.8 |
GO:0007289 |
spermatid nucleus differentiation(GO:0007289) |
| 0.1 |
0.2 |
GO:0019433 |
triglyceride catabolic process(GO:0019433) |
| 0.1 |
0.4 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.1 |
1.6 |
GO:0006490 |
oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.1 |
0.3 |
GO:0098501 |
polynucleotide dephosphorylation(GO:0098501) |
| 0.1 |
0.1 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.1 |
0.7 |
GO:1901385 |
regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.1 |
0.1 |
GO:0090267 |
positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
| 0.1 |
0.3 |
GO:0043181 |
vacuolar sequestering(GO:0043181) |
| 0.1 |
1.7 |
GO:0032933 |
response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
| 0.1 |
0.5 |
GO:0050901 |
leukocyte tethering or rolling(GO:0050901) |
| 0.1 |
0.8 |
GO:0060766 |
negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.1 |
0.5 |
GO:0010968 |
regulation of microtubule nucleation(GO:0010968) |
| 0.1 |
0.3 |
GO:2000505 |
regulation of energy homeostasis(GO:2000505) |
| 0.1 |
0.6 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.1 |
0.9 |
GO:0090074 |
negative regulation of protein homodimerization activity(GO:0090074) |
| 0.1 |
0.9 |
GO:0044794 |
positive regulation by host of viral process(GO:0044794) |
| 0.1 |
0.4 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.1 |
5.8 |
GO:0006487 |
protein N-linked glycosylation(GO:0006487) |
| 0.1 |
0.2 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.1 |
0.7 |
GO:0035418 |
protein localization to synapse(GO:0035418) |
| 0.1 |
1.5 |
GO:0001990 |
regulation of systemic arterial blood pressure by hormone(GO:0001990) |
| 0.1 |
0.6 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.1 |
0.3 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.1 |
0.4 |
GO:0032788 |
saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
| 0.1 |
0.4 |
GO:0010756 |
positive regulation of plasminogen activation(GO:0010756) |
| 0.1 |
1.3 |
GO:0010971 |
positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
| 0.1 |
0.6 |
GO:0009136 |
purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) |
| 0.1 |
0.1 |
GO:0010961 |
cellular magnesium ion homeostasis(GO:0010961) |
| 0.1 |
0.2 |
GO:0060693 |
regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
| 0.1 |
1.1 |
GO:0071786 |
endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.1 |
0.3 |
GO:0043928 |
exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.1 |
0.2 |
GO:0006681 |
galactosylceramide metabolic process(GO:0006681) galactolipid metabolic process(GO:0019374) |
| 0.1 |
0.5 |
GO:0045136 |
development of secondary sexual characteristics(GO:0045136) |
| 0.1 |
0.2 |
GO:0006678 |
glucosylceramide metabolic process(GO:0006678) |
| 0.1 |
0.2 |
GO:0045899 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.1 |
0.3 |
GO:0032486 |
Rap protein signal transduction(GO:0032486) |
| 0.1 |
2.4 |
GO:0003333 |
amino acid transmembrane transport(GO:0003333) |
| 0.1 |
0.3 |
GO:0034035 |
sulfate assimilation(GO:0000103) purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.1 |
0.5 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.1 |
0.4 |
GO:0090168 |
Golgi reassembly(GO:0090168) |
| 0.1 |
0.2 |
GO:1903147 |
negative regulation of mitophagy(GO:1903147) |
| 0.1 |
0.2 |
GO:0035990 |
tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.1 |
0.1 |
GO:0001575 |
globoside metabolic process(GO:0001575) |
| 0.1 |
0.5 |
GO:0015858 |
nucleoside transport(GO:0015858) |
| 0.1 |
0.4 |
GO:0002315 |
marginal zone B cell differentiation(GO:0002315) |
| 0.1 |
1.9 |
GO:0008089 |
anterograde axonal transport(GO:0008089) |
| 0.1 |
0.8 |
GO:0007143 |
female meiotic division(GO:0007143) |
| 0.1 |
0.4 |
GO:0051601 |
exocyst localization(GO:0051601) |
| 0.1 |
0.8 |
GO:0042182 |
ketone catabolic process(GO:0042182) |
| 0.1 |
0.4 |
GO:0006668 |
sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.1 |
0.2 |
GO:0000727 |
double-strand break repair via break-induced replication(GO:0000727) |
| 0.1 |
1.5 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.1 |
0.2 |
GO:0060696 |
regulation of phospholipid catabolic process(GO:0060696) |
| 0.1 |
0.4 |
GO:0070814 |
hydrogen sulfide biosynthetic process(GO:0070814) |
| 0.1 |
0.4 |
GO:0006842 |
tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.1 |
0.6 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
| 0.1 |
0.3 |
GO:0031112 |
positive regulation of microtubule polymerization or depolymerization(GO:0031112) |
| 0.1 |
0.9 |
GO:0001682 |
tRNA 5'-leader removal(GO:0001682) |
| 0.1 |
0.4 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.1 |
0.4 |
GO:0009301 |
snRNA transcription(GO:0009301) |
| 0.1 |
0.3 |
GO:0051792 |
medium-chain fatty acid biosynthetic process(GO:0051792) |
| 0.1 |
0.6 |
GO:0015919 |
peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
| 0.1 |
0.5 |
GO:0060837 |
blood vessel endothelial cell differentiation(GO:0060837) |
| 0.1 |
0.2 |
GO:0035694 |
mitochondrial protein catabolic process(GO:0035694) |
| 0.1 |
0.3 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 0.1 |
1.2 |
GO:0009395 |
phospholipid catabolic process(GO:0009395) |
| 0.1 |
0.4 |
GO:1902775 |
mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.1 |
0.2 |
GO:0030070 |
insulin processing(GO:0030070) |
| 0.1 |
1.3 |
GO:0072583 |
clathrin-mediated endocytosis(GO:0072583) |
| 0.1 |
0.4 |
GO:1902042 |
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
| 0.1 |
3.0 |
GO:0006779 |
porphyrin-containing compound biosynthetic process(GO:0006779) |
| 0.1 |
0.6 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.1 |
0.3 |
GO:0035720 |
intraciliary anterograde transport(GO:0035720) |
| 0.1 |
0.4 |
GO:0043416 |
regulation of skeletal muscle tissue regeneration(GO:0043416) |
| 0.1 |
0.1 |
GO:0010847 |
regulation of chromatin assembly(GO:0010847) |
| 0.1 |
1.1 |
GO:0035308 |
negative regulation of protein dephosphorylation(GO:0035308) |
| 0.1 |
0.1 |
GO:1903630 |
regulation of aminoacyl-tRNA ligase activity(GO:1903630) positive regulation of aminoacyl-tRNA ligase activity(GO:1903632) |
| 0.1 |
1.1 |
GO:0090162 |
establishment of epithelial cell polarity(GO:0090162) |
| 0.1 |
0.3 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 0.1 |
0.2 |
GO:0060166 |
olfactory pit development(GO:0060166) |
| 0.1 |
0.4 |
GO:0034441 |
plasma lipoprotein particle oxidation(GO:0034441) |
| 0.1 |
0.2 |
GO:0015882 |
L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.1 |
0.3 |
GO:0045602 |
negative regulation of endothelial cell differentiation(GO:0045602) |
| 0.1 |
0.8 |
GO:0051457 |
maintenance of protein location in nucleus(GO:0051457) |
| 0.1 |
0.1 |
GO:0006990 |
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.1 |
0.5 |
GO:0032264 |
IMP salvage(GO:0032264) |
| 0.1 |
0.2 |
GO:2000561 |
CD4-positive, alpha-beta T cell proliferation(GO:0035739) regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 0.1 |
0.4 |
GO:0006348 |
chromatin silencing at telomere(GO:0006348) |
| 0.1 |
0.1 |
GO:0090045 |
positive regulation of deacetylase activity(GO:0090045) |
| 0.1 |
0.1 |
GO:0060591 |
chondroblast differentiation(GO:0060591) |
| 0.1 |
0.1 |
GO:0051956 |
negative regulation of amino acid transport(GO:0051956) |
| 0.1 |
0.7 |
GO:0015937 |
coenzyme A biosynthetic process(GO:0015937) |
| 0.1 |
0.2 |
GO:0001692 |
histamine metabolic process(GO:0001692) |
| 0.1 |
0.3 |
GO:0007342 |
fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.1 |
0.2 |
GO:0046104 |
thymidine metabolic process(GO:0046104) |
| 0.1 |
0.8 |
GO:0002329 |
pre-B cell differentiation(GO:0002329) |
| 0.1 |
1.8 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
| 0.1 |
2.9 |
GO:0050905 |
neuromuscular process(GO:0050905) |
| 0.1 |
0.7 |
GO:0031268 |
pseudopodium organization(GO:0031268) |
| 0.1 |
0.5 |
GO:0061099 |
negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.1 |
0.2 |
GO:0035372 |
protein localization to microtubule(GO:0035372) |
| 0.1 |
0.5 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 0.1 |
0.1 |
GO:0021756 |
striatum development(GO:0021756) |
| 0.1 |
0.3 |
GO:0006515 |
misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
| 0.1 |
0.7 |
GO:0032967 |
positive regulation of collagen biosynthetic process(GO:0032967) |
| 0.1 |
0.4 |
GO:0006561 |
proline biosynthetic process(GO:0006561) |
| 0.1 |
0.7 |
GO:0034453 |
microtubule anchoring(GO:0034453) |
| 0.1 |
0.7 |
GO:0034551 |
respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.1 |
0.3 |
GO:0047497 |
establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.1 |
0.3 |
GO:0002437 |
inflammatory response to antigenic stimulus(GO:0002437) |
| 0.1 |
0.5 |
GO:0090280 |
positive regulation of calcium ion import(GO:0090280) |
| 0.1 |
0.1 |
GO:0090343 |
positive regulation of cell aging(GO:0090343) positive regulation of cellular senescence(GO:2000774) |
| 0.1 |
0.4 |
GO:2000074 |
regulation of type B pancreatic cell development(GO:2000074) |
| 0.1 |
0.4 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.1 |
2.9 |
GO:0007254 |
JNK cascade(GO:0007254) |
| 0.1 |
2.4 |
GO:0031532 |
actin cytoskeleton reorganization(GO:0031532) |
| 0.1 |
1.0 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.1 |
0.5 |
GO:0006699 |
bile acid biosynthetic process(GO:0006699) |
| 0.1 |
0.4 |
GO:0031293 |
membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.1 |
0.2 |
GO:0032693 |
negative regulation of interleukin-10 production(GO:0032693) |
| 0.1 |
0.2 |
GO:0006121 |
mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 0.1 |
0.2 |
GO:0019085 |
early viral transcription(GO:0019085) |
| 0.1 |
0.3 |
GO:0046292 |
formaldehyde metabolic process(GO:0046292) |
| 0.1 |
0.1 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.1 |
0.3 |
GO:0010863 |
positive regulation of phospholipase C activity(GO:0010863) |
| 0.1 |
0.3 |
GO:0032196 |
regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) transposition(GO:0032196) |
| 0.1 |
0.6 |
GO:0071578 |
zinc II ion transmembrane import(GO:0071578) |
| 0.1 |
0.3 |
GO:1900095 |
regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.1 |
0.2 |
GO:0046073 |
dTMP biosynthetic process(GO:0006231) dTMP metabolic process(GO:0046073) |
| 0.1 |
0.3 |
GO:0015816 |
glycine transport(GO:0015816) |
| 0.1 |
0.3 |
GO:0032469 |
endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
| 0.1 |
0.2 |
GO:0060576 |
intestinal epithelial cell development(GO:0060576) |
| 0.1 |
0.1 |
GO:2000642 |
negative regulation of vacuolar transport(GO:1903336) negative regulation of early endosome to late endosome transport(GO:2000642) |
| 0.1 |
0.8 |
GO:0002504 |
antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
| 0.1 |
0.1 |
GO:0031033 |
myosin filament organization(GO:0031033) myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
| 0.1 |
0.3 |
GO:0010452 |
histone H3-K36 methylation(GO:0010452) |
| 0.1 |
0.3 |
GO:1902591 |
single-organism membrane budding(GO:1902591) |
| 0.1 |
0.3 |
GO:0031115 |
negative regulation of microtubule polymerization(GO:0031115) |
| 0.1 |
0.1 |
GO:0032757 |
positive regulation of interleukin-8 production(GO:0032757) |
| 0.1 |
0.1 |
GO:0023035 |
CD40 signaling pathway(GO:0023035) |
| 0.1 |
0.5 |
GO:2000465 |
regulation of glycogen (starch) synthase activity(GO:2000465) |
| 0.1 |
1.0 |
GO:0007030 |
Golgi organization(GO:0007030) |
| 0.1 |
0.9 |
GO:0030968 |
endoplasmic reticulum unfolded protein response(GO:0030968) |
| 0.0 |
0.3 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 0.0 |
0.1 |
GO:2000035 |
regulation of stem cell division(GO:2000035) |
| 0.0 |
0.1 |
GO:0015886 |
heme transport(GO:0015886) |
| 0.0 |
0.2 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
| 0.0 |
0.1 |
GO:0060287 |
epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
| 0.0 |
0.1 |
GO:0097484 |
dendrite extension(GO:0097484) |
| 0.0 |
1.0 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.0 |
0.2 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 0.0 |
0.2 |
GO:0010884 |
positive regulation of lipid storage(GO:0010884) |
| 0.0 |
0.5 |
GO:1901216 |
positive regulation of neuron death(GO:1901216) |
| 0.0 |
0.1 |
GO:0042136 |
neurotransmitter biosynthetic process(GO:0042136) |
| 0.0 |
0.2 |
GO:0090084 |
negative regulation of inclusion body assembly(GO:0090084) |
| 0.0 |
1.4 |
GO:0030032 |
lamellipodium assembly(GO:0030032) |
| 0.0 |
0.1 |
GO:0009794 |
regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.0 |
0.3 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.0 |
0.4 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 0.0 |
0.2 |
GO:0009227 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
| 0.0 |
0.5 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.0 |
0.1 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.0 |
0.2 |
GO:0031848 |
protection from non-homologous end joining at telomere(GO:0031848) |
| 0.0 |
0.4 |
GO:0035999 |
tetrahydrofolate interconversion(GO:0035999) |
| 0.0 |
0.5 |
GO:0001539 |
cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
| 0.0 |
0.3 |
GO:0015936 |
coenzyme A metabolic process(GO:0015936) |
| 0.0 |
0.1 |
GO:0030951 |
establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.0 |
0.1 |
GO:0048714 |
positive regulation of oligodendrocyte differentiation(GO:0048714) |
| 0.0 |
0.2 |
GO:0071447 |
cellular response to hydroperoxide(GO:0071447) |
| 0.0 |
0.1 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.0 |
0.4 |
GO:0060712 |
spongiotrophoblast layer development(GO:0060712) |
| 0.0 |
0.1 |
GO:0015747 |
urate transport(GO:0015747) |
| 0.0 |
0.3 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.0 |
0.1 |
GO:0008206 |
bile acid metabolic process(GO:0008206) |
| 0.0 |
0.2 |
GO:0006108 |
malate metabolic process(GO:0006108) |
| 0.0 |
0.0 |
GO:0033603 |
positive regulation of dopamine secretion(GO:0033603) positive regulation of catecholamine secretion(GO:0033605) |
| 0.0 |
0.2 |
GO:0070127 |
tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.0 |
0.0 |
GO:1904627 |
response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
| 0.0 |
0.3 |
GO:0035774 |
positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
| 0.0 |
0.1 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.0 |
0.4 |
GO:0016239 |
positive regulation of macroautophagy(GO:0016239) positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
| 0.0 |
0.2 |
GO:0061088 |
sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
| 0.0 |
0.2 |
GO:0018364 |
peptidyl-glutamine methylation(GO:0018364) |
| 0.0 |
0.2 |
GO:0051560 |
mitochondrial calcium ion homeostasis(GO:0051560) |
| 0.0 |
0.3 |
GO:0001919 |
regulation of receptor recycling(GO:0001919) |
| 0.0 |
0.4 |
GO:0032418 |
lysosome localization(GO:0032418) |
| 0.0 |
0.5 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.0 |
0.2 |
GO:0003351 |
epithelial cilium movement(GO:0003351) |
| 0.0 |
0.3 |
GO:0098661 |
inorganic anion transmembrane transport(GO:0098661) |
| 0.0 |
0.1 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.0 |
0.3 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.0 |
0.1 |
GO:1902950 |
regulation of dendritic spine maintenance(GO:1902950) |
| 0.0 |
0.9 |
GO:0038083 |
peptidyl-tyrosine autophosphorylation(GO:0038083) |
| 0.0 |
0.1 |
GO:0070837 |
dehydroascorbic acid transport(GO:0070837) |
| 0.0 |
0.2 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.0 |
0.2 |
GO:0032781 |
positive regulation of ATPase activity(GO:0032781) |
| 0.0 |
0.1 |
GO:0060398 |
regulation of growth hormone receptor signaling pathway(GO:0060398) |
| 0.0 |
0.0 |
GO:0070257 |
positive regulation of mucus secretion(GO:0070257) |
| 0.0 |
0.0 |
GO:0033129 |
positive regulation of histone phosphorylation(GO:0033129) |
| 0.0 |
0.1 |
GO:0014807 |
regulation of somitogenesis(GO:0014807) |
| 0.0 |
0.1 |
GO:0034421 |
post-translational protein acetylation(GO:0034421) |
| 0.0 |
0.2 |
GO:0048240 |
sperm capacitation(GO:0048240) |
| 0.0 |
0.0 |
GO:0060510 |
Type II pneumocyte differentiation(GO:0060510) |
| 0.0 |
0.0 |
GO:0032074 |
negative regulation of nuclease activity(GO:0032074) |
| 0.0 |
1.1 |
GO:0018107 |
peptidyl-threonine phosphorylation(GO:0018107) |
| 0.0 |
0.3 |
GO:0048167 |
regulation of synaptic plasticity(GO:0048167) |
| 0.0 |
0.1 |
GO:0048820 |
hair follicle maturation(GO:0048820) |
| 0.0 |
0.2 |
GO:0007193 |
adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
| 0.0 |
0.2 |
GO:0090036 |
regulation of protein kinase C signaling(GO:0090036) |
| 0.0 |
0.0 |
GO:0015791 |
polyol transport(GO:0015791) |
| 0.0 |
0.2 |
GO:0072010 |
renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
| 0.0 |
0.0 |
GO:0000448 |
cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000448) |
| 0.0 |
0.3 |
GO:2000649 |
regulation of sodium ion transmembrane transporter activity(GO:2000649) |
| 0.0 |
0.1 |
GO:0045342 |
MHC class II biosynthetic process(GO:0045342) regulation of MHC class II biosynthetic process(GO:0045346) |
| 0.0 |
0.1 |
GO:0046579 |
positive regulation of Ras protein signal transduction(GO:0046579) |
| 0.0 |
0.1 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.0 |
0.3 |
GO:0032007 |
negative regulation of TOR signaling(GO:0032007) |
| 0.0 |
0.1 |
GO:1901655 |
cellular response to ketone(GO:1901655) |
| 0.0 |
0.1 |
GO:0048262 |
determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
| 0.0 |
0.1 |
GO:0033353 |
S-adenosylmethionine cycle(GO:0033353) |
| 0.0 |
0.1 |
GO:0036337 |
Fas signaling pathway(GO:0036337) |
| 0.0 |
0.1 |
GO:0009098 |
branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 0.0 |
0.1 |
GO:0006900 |
membrane budding(GO:0006900) |
| 0.0 |
0.1 |
GO:0008635 |
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.0 |
0.1 |
GO:0097428 |
protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.0 |
0.1 |
GO:0006451 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.0 |
0.1 |
GO:1990928 |
response to amino acid starvation(GO:1990928) |
| 0.0 |
0.0 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.0 |
0.9 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
| 0.0 |
0.1 |
GO:0044804 |
nucleophagy(GO:0044804) |
| 0.0 |
0.1 |
GO:0032456 |
endocytic recycling(GO:0032456) |
| 0.0 |
0.1 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.0 |
0.1 |
GO:0007000 |
nucleolus organization(GO:0007000) |
| 0.0 |
0.1 |
GO:0080009 |
mRNA methylation(GO:0080009) |
| 0.0 |
0.2 |
GO:0010758 |
regulation of macrophage chemotaxis(GO:0010758) |
| 0.0 |
0.0 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.0 |
0.2 |
GO:0015991 |
ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.0 |
0.0 |
GO:0010792 |
DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 0.0 |
0.1 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.0 |
0.1 |
GO:0051292 |
nuclear pore complex assembly(GO:0051292) |
| 0.0 |
0.0 |
GO:0002946 |
tRNA C5-cytosine methylation(GO:0002946) |
| 0.0 |
0.1 |
GO:0006672 |
ceramide metabolic process(GO:0006672) |
| 0.0 |
0.1 |
GO:0097300 |
programmed necrotic cell death(GO:0097300) |
